IL6 and systemic sclerosis: Moreover, roscovitine caused a proportionately greater reduction in IL-6 production by SSc fibroblasts than by normal cells, suggesting that SSc fibroblasts may be more sensitive to the anti-fibrotic effects of roscovitine.